Literature DB >> 17511776

Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France.

A Faye1, S Pornprasert, J-Y Mary, G Dolcini, M Derrien, F Barré-Sinoussi, G Chaouat, E Menu.   

Abstract

Cytokines are involved in regulating HIV-1 infection. They are also placental environment major components. We assessed the potential impact of HIV-1 infection and/or anti-retroviral drugs on the placental cytokine profiles that may be involved in controlling HIV-1 placental dissemination. Placental explants were obtained after elective caesarean section from anti-retroviral-treated HIV-1-infected pregnant women and from HIV-1 non-infected pregnant women. The main placental cytokines were assessed for protein secretion in the supernatants of 24-h placental culture explants and/or in uncultured placental explants for mRNA expression levels. The cytokine profiles were different between the HIV-1-infected and the non-infected groups. Higher medians of leukaemia inhibiting factor (LIF), tumour necrosis factor (TNF)-alpha and interleukin (IL)-8 secretion were found in the 24-h culture supernatant of term placenta from HIV-1-infected women. High median levels of IL-16 and regulated upon activation normal T cell expressed and secreted (RANTES) levels were found in both groups. The mRNA expression medians were lower for TNF-alpha and IL-8 and higher for stromal cell-derived factor-1 (SDF-1) in uncultured placental explants from HIV-1-infected women. In the HIV-1-infected group, but not in the non-infected group, the secretion levels of TNF-alpha and IL-8, as well as their mRNA expression levels, were highly positively correlated; furthermore, their secretion levels were correlated positively with LIF and IL-10 secretion levels. We found no correlation between the cytokine levels and the immunovirological status of the HIV-1-infected mothers or the type or duration of treatment. These results highlight the potential impact of HIV-1 and of the anti-retroviral treatments on the placental cytokines pattern, independently of their anti-viral activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17511776      PMCID: PMC2219329          DOI: 10.1111/j.1365-2249.2007.03411.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  58 in total

1.  Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  R S Sperling; D E Shapiro; R W Coombs; J A Todd; S A Herman; G D McSherry; M J O'Sullivan; R B Van Dyke; E Jimenez; C Rouzioux; P M Flynn; J L Sullivan
Journal:  N Engl J Med       Date:  1996-11-28       Impact factor: 91.245

2.  IL-10 prevents naturally occurring fetal loss in the CBA x DBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-tau.

Authors:  G Chaouat; A Assal Meliani; J Martal; R Raghupathy; J F Elliott; J Elliot; T Mosmann; T G Wegmann
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

3.  Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

Authors:  L M Mofenson; J S Lambert; E R Stiehm; J Bethel; W A Meyer; J Whitehouse; J Moye; P Reichelderfer; D R Harris; M G Fowler; B J Mathieson; G J Nemo
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

Review 4.  Cytokine network at the feto-maternal interface.

Authors:  S Saito
Journal:  J Reprod Immunol       Date:  2000-07       Impact factor: 4.054

Review 5.  Vertical transmission of HIV: parameters which might affect infection of placental trophoblasts by HIV-1: a review. Biomed Group on the Study of in Utero Transmission of HIV 1.

Authors:  M Moussa; B Mognetti; S Dubanchet; E Menu; P Roques; G Gras; D Dormont; F Barre-Sinoussi; G Chaouat
Journal:  Am J Reprod Immunol       Date:  1999-05       Impact factor: 3.886

6.  RANTES, IFN-gamma, CCR1, and CCR5 mRNA expression in peripheral blood, lymph node, and bronchoalveolar lavage mononuclear cells during primary simian immunodeficiency virus infection of macaques.

Authors:  A Chéret; R Le Grand; P Caufour; O Neildez; F Matheux; F Théodoro; B Vaslin; D Dormont
Journal:  Virology       Date:  1999-03-15       Impact factor: 3.616

7.  Selection of maternal human immunodeficiency virus type 1 variants in human placenta. European Network for In Utero Transmission of HIV-1.

Authors:  E Menu; F X Mbopi-Keou; S Lagaye; S Pissard; P Mauclère; G Scarlatti; J Martin; M Goossens; G Chaouat; F Barré-Sinoussi; F X M'bopi Kéou
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

8.  Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women.

Authors:  B K Patterson; H Behbahani; W J Kabat; Y Sullivan; M R O'Gorman; A Landay; Z Flener; N Khan; R Yogev; J Andersson
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

9.  Suppression of leukemia inhibitor factor in lymphoid tissue in primary HIV infection: absence of HIV replication in gp130-positive cells.

Authors:  Annelie Tjernlund; Zareefa Fleener; Homira Behbahani; Elizabeth Connick; Anders Sönnerborg; Christina Broström; Li-Ean Goh; Anna-Lena Spetz; Bruce K Patterson; Jan Andersson
Journal:  AIDS       Date:  2003-06-13       Impact factor: 4.177

10.  [In vitro modulation of the production of the cytokine HILDA/LIF, secreted by human endometrial explants: preliminary results].

Authors:  G Delage; J F Moreau; J L Taupin; E Hambartsoumian; R Frydman; B Tartzkovsky; G Chaouat
Journal:  Contracept Fertil Sex       Date:  1995-10
View more
  19 in total

1.  Do children exposed to human immunodeficiency virus but not infected actually have a more robust response to hepatitis B vaccination than their nonexposed peers?

Authors:  Olivia Swann; Ewen M Harrison
Journal:  Clin Vaccine Immunol       Date:  2012-02

2.  Measles Immunity at 4.5 Years of Age Following Vaccination at 9 and 15-18 Months of Age Among Human Immunodeficiency Virus (HIV)-infected, HIV-exposed-uninfected, and HIV-unexposed Children.

Authors:  Eleonora A M L Mutsaerts; Marta C Nunes; Martijn N van Rijswijk; Kerstin Klipstein-Grobusch; Kennedy Otwombe; Mark F Cotton; Avy Violari; Shabir A Madhi
Journal:  Clin Infect Dis       Date:  2019-08-01       Impact factor: 9.079

3.  Effect of HIV exposure and timing of antiretroviral therapy initiation on immune memory responses to diphtheria, tetanus, whole cell pertussis and hepatitis B vaccines.

Authors:  Omphile E Simani; Alane Izu; Marta C Nunes; Avy Violari; Mark F Cotton; Nadia Van Niekerk; Peter V Adrian; Shabir A Madhi
Journal:  Expert Rev Vaccines       Date:  2018-11-19       Impact factor: 5.217

4.  Insights Into Circulating Cytokine Dynamics During Pregnancy in HIV-Infected Beninese Exposed to Plasmodium falciparum Malaria.

Authors:  Samad A Ibitokou; Lise Denoeud-Ndam; Sèm Ezinmegnon; Rodolphe Ladékpo; Djimon-Marcel Zannou; Achille Massougbodji; Pierre-Marie Girard; Michel Cot; Adrian J F Luty; Nicaise Tuikue Ndam
Journal:  Am J Trop Med Hyg       Date:  2015-06-22       Impact factor: 2.345

5.  Impaired humoral response to vaccines among HIV-exposed uninfected infants.

Authors:  Beatriz Mariana Abramczuk; Taís Nitsch Mazzola; Yara Maria Franco Moreno; Tatiane Queiroz Zorzeto; Wagner Quintilio; Paulo Silva Wolf; Maria Heloisa Blotta; André Moreno Morcillo; Marcos Tadeu Nolasco da Silva; Maria Marluce Dos Santos Vilela
Journal:  Clin Vaccine Immunol       Date:  2011-07-20

6.  Effect of multivitamin supplementation on measles vaccine response among HIV-exposed uninfected Tanzanian infants.

Authors:  Christopher R Sudfeld; Christopher Duggan; Alex Histed; Karim P Manji; Simin N Meydani; Said Aboud; Molin Wang; Edward L Giovannucci; Wafaie W Fawzi
Journal:  Clin Vaccine Immunol       Date:  2013-05-29

7.  Immunogenicity of Hepatitis B Vaccine in HIV Exposed Uninfected Infants.

Authors:  Dharmendra K Singh; Rajnish Kumar; Ruchi Rai; Manisha Maurya; Anudita Bhargava
Journal:  Indian J Pediatr       Date:  2015-10-10       Impact factor: 1.967

8.  Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life.

Authors:  Brian A Reikie; Shalena Naidoo; Candice E Ruck; Amy L Slogrove; Corena de Beer; Heleen la Grange; Rozanne C M Adams; Kevin Ho; Kinga Smolen; David P Speert; Mark F Cotton; Wolfgang Preiser; Monika Esser; Tobias R Kollmann
Journal:  Clin Vaccine Immunol       Date:  2012-10-31

9.  Severity of maternal HIV-1 disease is associated with adverse birth outcomes in Malawian women: a cohort study.

Authors:  Abigail Norris Turner; Sammy Tabbah; Victor Mwapasa; Stephen J Rogerson; Steven R Meshnick; William E Ackerman; Jesse J Kwiek
Journal:  J Acquir Immune Defic Syndr       Date:  2013-12-01       Impact factor: 3.731

10.  Higher Transplacental Pathogen-Specific Antibody Transfer Among Pregnant Women Randomized to Triple Antiretroviral Treatment Versus Short Course Zidovudine.

Authors:  Rose Bosire; Carey Farquhar; Ruth Nduati; Kristina Broliden; Stanley Luchters; Philippe Van de Perre; Isabelle De Vincenzi; Michele Merkel; Veronicah Wachuka; Dorothy Mbori-Ngacha; Grace John-Stewart; Barbara Lohman-Payne; Marie Reilly
Journal:  Pediatr Infect Dis J       Date:  2018-03       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.